Neurofilament Light Chain Levels, Skeletal Muscle Loss, and Nutritional Decline: Key Prognostic Factors in Amyotrophic Lateral Sclerosis
Muscle & Nerve · 2025
DOI: 10.1002/mus.28407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Aida Zulueta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurorehabilitation of the Milan Institute, Istituti Clinici Scientifici Maugeri IRCCS, Milan, Italy. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Neurofilament Proteins, Malnutrition, Nutritional Status. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction/Aims Hypermetabolism and weight loss are established negative prognostic factors in amyotrophic lateral sclerosis (ALS). However, the role of individualized body composition parameters in predicting ALS progression has been underexplored. This study aimed to investigate the correlation between nutritional parameters, neurofilament light chain (NfL) levels, and disease progression in ALS patients.
Methods
The Global Leadership Initiative on Malnutrition criteria were used to define malnutrition in this study. Nutritional status was assessed using body mass index and bioelectrical impedance analysis. The rate of disease progression was defined by the change in the Revised ALS Functional Rating Scale score (ΔFRS). NfL was quantified using single molecule array technology. Spearman's analyses were used to assess correlations.
Results
Sixty of 110 ALS patients were classified as malnourished. There was a strong positive correlation between NfL and ΔFRS ( r = 0.71), and a moderate negative correlation with disease duration ( r = −0.55). The correlations between NfL and body composition parameters were statistically significant, although weak. NfL levels were significantly higher in fast progressors ( p < 0.0001 compared to slow progressors) and in malnourished patients ( p = 0.0001). Of the 34 fast progressor patients, 28 (82%) exhibited some degree of malnutrition.
Discussion
Our findings indicate that poor nutritional status, particularly reduced skeletal muscle mass—both independently and in combination with fat mass loss—is associated with elevated NfL levels and faster ALS progression. NfL, combined with nutritional parameters, could serve as a valuable biomarker for disease severity. Further research is warranted to clarify the role of skeletal muscle abnormalities in ALS progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurorehabilitation of the Milan Institute, Istituti Clinici Scientifici Maugeri IRCCS, Milan, Italy.
- Geriatric Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
- Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy.
- IRCCS MultiMedica, Milan, Italy.
ORCID-Profile: Aida Zulueta
Zitieren
APA
Zulueta, A., Piras, R., Azzolino, D., Mariani, P., Sideri, R., Garrè, C., Federico, G., Lucchi, T., Magni, P., Parati, E. A., & Lunetta, C. (2025). Neurofilament Light Chain Levels, Skeletal Muscle Loss, and Nutritional Decline: Key Prognostic Factors in Amyotrophic Lateral Sclerosis. Muscle & Nerve. https://doi.org/10.1002/mus.28407
Vancouver
Zulueta A, Piras R, Azzolino D, Mariani P, Sideri R, Garrè C, et al. Neurofilament Light Chain Levels, Skeletal Muscle Loss, and Nutritional Decline: Key Prognostic Factors in Amyotrophic Lateral Sclerosis. Muscle & Nerve. 2025. doi:10.1002/mus.28407
BibTeX
@article{Zulueta2025,
author = {Zulueta, Aida and Piras, Rachele and Azzolino, Domenico and Mariani, Paola and Sideri, Riccardo and Garrè, Camilla and Federico, Giuliana and Lucchi, Tiziano and Magni, Paolo and Parati, Eugenio Agostino and Lunetta, Christian},
title = {Neurofilament Light Chain Levels, Skeletal Muscle Loss, and Nutritional Decline: Key Prognostic Factors in Amyotrophic Lateral Sclerosis},
journal = {Muscle & Nerve},
year = {2025},
doi = {10.1002/mus.28407}
}
EUVIMED